EMAHSN Governance boardChaired by our Independent Chair, the Governance Board focuses on scrutiny and assurance of:
Financial, performance and risk managementDelivery against EMAHSN strategy and Business PlanEquality Impact and action
The Governance Board members are required to adopt governance best practice.
The cycle of reporting and continuous assessment quickly and effectively identifies if and when remedial action if needed and enables timely decisions to be made about the continuation of a project or programme.
The Governance Board members are:
Martin Hindle - EMAHSN Independent Chair
The former Chairman of University Hospitals of Leicester NHS Trust (UHL). He has held leadership roles in both industry and health organisations. He was Chief Executive of the Nordic Region for the French company, Rhone Poulenc, Chairman and Chief Executive of Fisons' French operation, Global Commercial Director for Fisons pharmaceutical division and a Chief Executive Officer at Cable and Wireless and Wireless Nautec. Martin is a non-executive Director (NED) of Public Health England and the Medicines and Healthcare Products Regulatory Agency (MHRA). He was previously a NED for the National Blood Authority, National Biological Standards Board and the Health Protection Agency.
Dr Peter Homa CBE Vice-Chair of the Board
Peter has been Chief Executive of Nottingham University Hospitals NHS Trust since 2006, following senior management roles in London, Bristol, Redditch, Worcestershire and Leicester leading management practice to improve quality, value for money teaching and research. Peter created and led the National Patients' Access Team and was foundation Chief Executive of the Commission for Health Improvement and is a visiting Professor for Healthcare Management in the Universities of Sussex and Lincoln. In 2014 Peter was highlighted as one of the country's top 10 hospital chief executives by the Health Service Journal.
Dr Janet Worrell Independent Board Member
Janet is a Director of consult2deliver limited, specialising in creative clinical and regulatory solutions for healthcare and bioscience sectors. Janet is a pharmacist and an experienced regulatory affairs professional, having supported a diverse portfolio of products for a number of companies across the East Midlands. She has developed products for UK, Europe, ASEAN and USA markets. Janet's skillset covers early concept development, scientific advice, food supplements, over the counter (OTC) medicines, inhaled therapies and clinical trial applications.
Mike Wilkins Independent Board Member
Mike has a working background spanning the private, public, not-for-profit and non-departmental public body sectors. He worked in the Nottingham textile industry and in sales and marketing with Cadbury Schweppes before qualifying as a social worker and spending 13 years working in both Nottingham city and county as a practitioner and manager. His most recent post was as Regional Manager for East Midlands/East of England with Capacitybuilders, the Cabinet Office agency responsible for funding and developing infrastructure support for the voluntary and community sector. He is currently an Associate Lay Membe for Nottingham North and East Clinical Commissioning Group and is a trustee and treasurer of the charity, WaterWorks, providing clean drinking water and sanitation in the rural villages of Malawi.
Mike Hannay EMAHSN Managing Director
Professor Mike Hannay has more than 25 years’ experience of working in the pharmaceutical industry, with an excellent track record of building collaboration with healthcare. Mike joined EMAHSN in August 2016 from ThermoFisher Scientific, where he was Vice President for the UK BioPharma Services Division. That role built upon his significant experience both nationally and internationally, including Vice President of Medicines Development at AstraZeneca.
Margaret Woolley EMAHSN Director of Operations
Margaret has undertaken a wide range of NHS governance and programme management roles, at organisational, regional and national level. Margaret joined EMAHSN having worked within the team establishing the NHS Commissioning Board and prior to that was Assistant Chief Executive at East Midlands Strategic Health Authority.
Mark Russell Co-Chair East Midlands PPI Senate
Mark is a patient and carer, the Patient representative on Nottingham West Clinical Commissioning Group Governing Body and Chair of his General Practice's PPG. He chairs/participates in other groups, locally and regionally. Previously he had 33 years NHS experience in various senior manager roles (including as Chief Executive). He currently operates an Organisational Development Consultancy.